Doyle Adam J, Redmond Eileen M, Gillespie David L, Knight Peter A, Cullen John P, Cahill Paul A, Morrow David J
Department of Surgery, University of Rochester Medical Center, Rochester, NY.
Heart and Vascular Center, South Coast Health Systems, Fall River/New Bedford, Mass.
J Vasc Surg. 2015 Aug;62(2):464-70. doi: 10.1016/j.jvs.2014.02.053. Epub 2014 Apr 24.
The molecular mechanisms leading to the development of abdominal aortic aneurysms (AAAs) remain poorly understood. The aim of this study was to determine the expression of Sonic Hedgehog (SHh), transforming growth factor β (TGF-β), and Notch signaling components in human aneurysmal and nonaneurysmal aorta in vivo.
Paired tissue samples were obtained from aneurysmal and nonaneurysmal (control) segments of the aortic wall of eight patients with suitable anatomy undergoing open repair of infrarenal AAAs. Protein and messenger RNA (mRNA) expression levels were determined by Western blot and quantitative real-time polymerase chain reaction analysis.
Aneurysm development resulted in a significant reduction in vascular smooth muscle (vSMC) differentiation genes α-actin and SMC22α at both mRNA and protein levels. In parallel experiments, an 80.0% ± 15% reduction in SHh protein expression was observed in aneurysmal tissue compared with control. SHh and Ptc-1 mRNA levels were also significantly decreased, by 82.0% ± 10% and 75.0% ± 5%, respectively, in aneurysmal tissue compared with nonaneurysmal control tissue. Similarly, there was a 50.0% ± 9% and 60.0% ± 4% reduction in Notch receptor 1 intracellular domain and Hrt-2 protein expression, respectively, in addition to significant reductions in Notch 1, Notch ligand Delta like 4, and Hrt-2 mRNA expression in aneurysmal tissue compared with nonaneurysmal tissue. There was no change in Hrt-1 expression observed in aneurysmal tissue compared with control. In parallel experiments, we found a 2.2 ± 0.2-fold and a 5.6 ± 2.2-fold increase in TGF-β mRNA and protein expression, respectively, in aneurysmal tissue compared with nonaneurysmal tissue. In vitro, Hedgehog signaling inhibition with cyclopamine in human aortic SMCs resulted in decreased Hedgehog/Notch signaling component and vSMC differentiation gene expression. Moreover, cyclopamine significantly increased TGF-β1 mRNA expression by 2.6 ± 0.9-fold.
These results suggest that SHh/Notch and TGF-β signaling are differentially regulated in aneurysmal tissue compared with nonaneurysmal tissue. Changes in these signaling pathways and the resulting changes in vSMC content may play a causative role in the development of AAAs.
导致腹主动脉瘤(AAA)发生发展的分子机制仍未完全明确。本研究旨在确定人动脉瘤性和非动脉瘤性主动脉中 Sonic Hedgehog(SHh)、转化生长因子β(TGF-β)及 Notch 信号通路相关成分的体内表达情况。
从 8 例接受肾下腹主动脉瘤开放修复且解剖结构合适的患者的主动脉壁动脉瘤段和非动脉瘤段(对照)获取配对组织样本。通过蛋白质印迹法和定量实时聚合酶链反应分析确定蛋白质和信使核糖核酸(mRNA)的表达水平。
动脉瘤形成导致血管平滑肌(vSMC)分化基因α-肌动蛋白和 SMC22α在 mRNA 和蛋白质水平均显著降低。在平行实验中,与对照相比,动脉瘤组织中 SHh 蛋白表达降低了 80.0%±15%。与非动脉瘤对照组织相比,动脉瘤组织中 SHh 和 Ptc-1 mRNA 水平也分别显著降低了 82.0%±10%和 75.0%±5%。同样,与非动脉瘤组织相比,动脉瘤组织中 Notch 受体 1 胞内结构域和 Hrt-2 蛋白表达分别降低了 50.0%±9%和 60.0%±4%,此外,Notch 1、Notch 配体 Delta like 4 和 Hrt-2 mRNA 表达也显著降低。与对照相比,未观察到动脉瘤组织中 Hrt-1 表达有变化。在平行实验中,与非动脉瘤组织相比,我们发现动脉瘤组织中 TGF-β mRNA 和蛋白质表达分别增加了 2.2±0.2 倍和 5.6±2.2 倍。在体外,用环杷明抑制人主动脉平滑肌细胞中的 Hedgehog 信号通路导致 Hedgehog/Notch 信号通路相关成分及 vSMC 分化基因表达降低。此外,环杷明显著增加 TGF-β1 mRNA 表达 2.6±0.9 倍。
这些结果表明,与非动脉瘤组织相比,动脉瘤组织中 SHh/Notch 和 TGF-β信号通路受到不同调节。这些信号通路的变化以及由此导致的 vSMC 含量变化可能在 AAA 的发生发展中起因果作用。